Education
About Us
Working with TipRanks
Follow Us
Evoke Pharma Inc (EVOK)
:EVOK
EVOK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.94 - $12.32
Previous CloseN/A
Volume6.47K
Average Volume (3M)300.39K
Market Cap
$7.64M
Enterprise Value-$292.02K
Total Cash (Recent Filing)$12.62M
Total Debt (Recent Filing)$144.84K
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Nov 05, 2025EPS Estimate
-0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding1,558,465
10 Day Avg. Volume24,976
30 Day Avg. Volume300,386
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap-0.04
Enterprise Value/Revenue-0.03
Enterprise Value/Gross Profit-0.03
Enterprise Value/Ebitda0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evoke Pharma News
EVOK FAQ
What was Evoke Pharma Inc’s price range in the past 12 months?
Evoke Pharma Inc lowest stock price was $1.94 and its highest was $12.32 in the past 12 months.
What is Evoke Pharma Inc’s market cap?
Evoke Pharma Inc’s market cap is $7.64M.
When is Evoke Pharma Inc’s upcoming earnings report date?
Evoke Pharma Inc’s upcoming earnings report date is Nov 05, 2025 which is in 38 days.
How were Evoke Pharma Inc’s earnings last quarter?
Evoke Pharma Inc released its earnings results on Aug 14, 2025. The company reported -$0.62 earnings per share for the quarter, missing the consensus estimate of -$0.3 by -$0.32.
Is Evoke Pharma Inc overvalued?
According to Wall Street analysts Evoke Pharma Inc’s price is currently Overvalued.
Does Evoke Pharma Inc pay dividends?
Evoke Pharma Inc does not currently pay dividends.
What is Evoke Pharma Inc’s EPS estimate?
Evoke Pharma Inc’s EPS estimate is -0.45.
How many shares outstanding does Evoke Pharma Inc have?
Evoke Pharma Inc has 1,558,465 shares outstanding.
What happened to Evoke Pharma Inc’s price movement after its last earnings report?
Evoke Pharma Inc reported an EPS of -$0.62 in its last earnings report, missing expectations of -$0.3. Following the earnings report the stock price went up 4.26%.
Which hedge fund is a major shareholder of Evoke Pharma Inc?
Currently, no hedge funds are holding shares in EVOK
Company Description
Evoke Pharma Inc
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Technical Analysis
China Pharma Holdings
―
Sonoma Pharmaceuticals
―
Shineco
―
Sunshine Biopharma
―
IM Cannabis Corp
―
Ownership Overview
51.39% Insiders
0.67% Mutual Funds
13.92% Other Institutional Investors
33.91% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---